McGovern and Smith [1] have embarked upon the welcome development of
an evidence based algorithm for the investigation of infants presenting
with an apparent life threatening event (ALTE). Unfortunately, they do not
distinguish between coincidence and causality. Recurrent vomiting occurs
in over 60% of 4 month old babies [2], and it is therefore unsurprising
that gastro-oesophageal reflux is commonly...
McGovern and Smith [1] have embarked upon the welcome development of
an evidence based algorithm for the investigation of infants presenting
with an apparent life threatening event (ALTE). Unfortunately, they do not
distinguish between coincidence and causality. Recurrent vomiting occurs
in over 60% of 4 month old babies [2], and it is therefore unsurprising
that gastro-oesophageal reflux is commonly found in infants presenting
with ALTEs. The aim of their study was to determine the diagnoses
reported after the first evaluation of an ALTE, but the paper’s title then
somewhat misleadingly refers to “causes” of ALTE.
Despite the fact that in six of the eight studies analysed, patients
did not routinely undergo pH monitoring, one of the most common diagnoses
made was ‘gastro-oesophageal reflux disease’ (GORD). This begs the
question as to whether most if not all of the children merely had
physiological gastro-oesophageal reflux (GOR), wrongly defined as GORD,
simply because of the ALTE under investigation – an unwarranted assumption
of causality. Moreover, they fail to point out that the milk scans and
contrast studies used in some of their cited studies have unacceptably low
sensitivity and specificity in the diagnosis of non-physiological GOR.
Their suggested plan of investigation acknowledges that in around 50%
of infants experiencing an ALTE, a careful history and examination will
point to an underlying diagnosis. Conversely, in the absence of other
symptoms (e.g. vomiting) they imply it may be important to identify and
treat occult reflux by recommending investigating for GOR. Demonstration
of a significant temporal relationship between lower oesophageal
acidification and apnoea is crucial in establishing a causal hypothesis
linking the two. However, when Arad-Cohen explored the relationship
between GOR and apnoea in infants with a history of ALTE [3] during
polygraphic recording, only 19% of 741 brief apnoeas were coupled with
GOR, and of these, apnoea preceded rather than followed GOR in the vast
majority. The concept of an ‘ALTE – Sudden Infant Death’ spectrum in which
GOR plays an important role is no longer widely accepted [4].
We argue that there is no need to perform tests for GOR unless there
is a suggestive clinical history such as vomiting during or after feeds,
poor weight gain, feed refusal, etc. Under these circumstances pH
monitoring (whatever its limitations) [4] remains the investigation of
choice. A reliance principally on contrast studies and clinical history is
likely to mean that physiological ‘GOR’ will be diagnosed as ‘GORD’. This
may lead not only to unnecessary treatment, but also focus attention away
from serious disorders including factitious illness [5]. We regard pH
monitoring in children who have experienced an ALTE but have no clinical
pointers to GORD as being of little value, and contend that there is no
evidence base for such an approach.
References
(1). McGovern MC, Smith MBH. Causes of apparent life threatening events
in infants: a systematic review. Arch Dis Child 2004;8:1043-48
(2). Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of
symptoms of gastroesophageal reflux during infancy. Arch Paediatric
Adolesc Med 1997;151:569-572
(3). Arad-Cohen N, Cohen A, Tirosh E. The relationship between
gastroesophageal reflux and apnea in infants. J Pediatr 2000;137:321-36
(4). Puntis JWL. ‘Apparent life threatening events’ in sleeping
infants: is gastroesophageal reflux ever to blame? J Clinical Forensic
Medicine 2003:10:97-101
(5). Meadow R. Suffocation, recurrent apnea, and sudden infant death. J
Pediatrics 1990;117:352-7
In reading this piece and the published response concerning the
merits of personal interviews in child protection cases, I was struck by
the sentence introducing the topic which reads: "Most paediatricians would
not dream of giving a clinical opinion without taking a history".
Accordingly this week I kept a diary of clinical opinions given. It was a
quiet week "off service", there were only...
In reading this piece and the published response concerning the
merits of personal interviews in child protection cases, I was struck by
the sentence introducing the topic which reads: "Most paediatricians would
not dream of giving a clinical opinion without taking a history".
Accordingly this week I kept a diary of clinical opinions given. It was a
quiet week "off service", there were only 47; 24 on rounds, 9 in clinic
and 14 by phone, letter or email. Among these, I met the child and parents
and exchanged words with them in only 10. I took a history myself in only
7. I do infectious diseases and immunology not child protection, but I
reckon this is how consultants work in all areas.
Professor David's article [1] was, in the majority a helpful guide to
those involved in this specialised work. I wonder how many of the readers
are involved in this sort of work?
As a recently qualified general paediatrician I was surprised to read
his recommendation that expert witnesses should interview the family. In
the few child protection cases that I have been involved in as a witnes...
Professor David's article [1] was, in the majority a helpful guide to
those involved in this specialised work. I wonder how many of the readers
are involved in this sort of work?
As a recently qualified general paediatrician I was surprised to read
his recommendation that expert witnesses should interview the family. In
the few child protection cases that I have been involved in as a witness
to the fact colleagues acting as expert witnesses have not interviewed the
family. They have restricted themselves to their expert opinions on
specific questions of medical knowledge that the legal teams have felt
would be helpful to clarify. I read that other expert witnesses agree. [2]
I was also surprised to read Professor David's views without a
response from those who have differing opinons, especially as he is
intimately involved in Professor Southall's controversial General Medical
Council hearing. I do trust that you will uphold the esential principle of
good journalism and allow an open debate on this issue with equal
prominence to differing views.
References
(1). Avoidable pitfalls when writing medical reports for court
proceedings in cases of suspected child abuse. David TJ. Arch. Dis.
Child. 2004; 89: 799-804
Expert Witnesses: Opinion and dogma are pitfalls in medical journalism as
well as in reports.
(2). Paul M Davis, Margaret Crawford, Jean Herbison, Jacqueline Mok,
Alison Mott, Heather Payne, Robert Postlethwaite, Jean Price, Martin
Samuels, Jo Sibert, John Sills, and Nigel Speight (4 November 2004)
I enjoyed Ricci et al's article on the ' Pitfalls of adverse event
reporting..'.This is a difficult issue for medical departments.As well as
a robust reporting system it is important to have a forum to deal with the
incidents and educate staff.
Our paediatric unit has had a Clinical Practice Meeting for the past 2
years. This happens every 6-8 weeks, it is multidisciplinary
(nursing,doc...
I enjoyed Ricci et al's article on the ' Pitfalls of adverse event
reporting..'.This is a difficult issue for medical departments.As well as
a robust reporting system it is important to have a forum to deal with the
incidents and educate staff.
Our paediatric unit has had a Clinical Practice Meeting for the past 2
years. This happens every 6-8 weeks, it is multidisciplinary
(nursing,doctors, pharmacist and clinical risk manager). It is anonymous
and non-threatening with the emphasis being on reviewing our systems and
education. We are also not good at reporting 'near misses' and this is
very difficult to monitor. We had planned to audit our incidents and I
think it will be interesting to look at which staff report which
incidents.
I would recommend this type of meeting for raising staff awareness and making changes to unsafe practices.
yours sincerely,
There is a bias in research on treatments that sometimes manifests
itself in odd ways. The preference for a one-tailed test, for instance,
may lead us to focus on whether a treatment makes things better, but leads
us to miss important details when a treatment makes things worse. This is
an important point when testing treatments against such alternatives.
There is a bias in research on treatments that sometimes manifests
itself in odd ways. The preference for a one-tailed test, for instance,
may lead us to focus on whether a treatment makes things better, but leads
us to miss important details when a treatment makes things worse. This is
an important point when testing treatments against such alternatives.
Before turning to the central point, however, there is the issue of
statistical power that was noticeable by its absence in the Olafsdottir
study [1]. It is worth noting that if a clinically meaningful difference of
.5 of a standard deviation was to be detected with a two-tailed test, then
given this sample size, there was a 63% chance of doing so (or 74% with a
one-tailed test). Such information is always worth including when a non-
result of this order is reported.
To the central point, Olafsdottir [1] et al note that a chiropractic
manipulation performed significantly better than a drug, but did not note
the plausible hypothesis that dimethicone is not only 'not better than
placebo,' but for some infants may make things worse, perhaps because
activated dimethicone used alone (ie., without an antacid component, as in
Altacite Plus) causes the large bubbles to redistribute stomach acid along
the esophagus when belching, thereby irritating the child more than the
relief that is obtained from the expulsion of gas.
The relatively high attrition rate and poor outcomes in the Wiberg [2]
study's dimethicone group is consistent with the possibility that they
used an alternative that not only doesn't work for some, but makes things
worse instead of better for others. Thus, the the comparsion of
chiropractic methods to *nocebo* is scarcely the same as a comparison
against *placebo*. It is good to see the publication of a non-result such
as that shown by Olafsdottir, et al[1] which uses a true placebo
treatment to illustrate the non-effect of chiropractic methods.
References
(1). E Olafsdottir, S Forshei, G Fluge, and T Markestad.
Randomised controlled trial of infantile colic treated with chiropractic
spinal manipulation. Arch. Dis. Child. 2001; 84: 138-141
(2). Wiberg JMM, Nordsteen J, Nilsson N. The short-term effect of
spinal manipulation in the treatment of infantile colic: A randomized
controlled clinical trial with a blinded observer. J Manipulative Physiol
Ther 1999;22:517-22.
Olusanya et al debate the principles of informed choice within the
context of infant hearing screening [1]. In doing so they draw upon our
conceptualisation and measure of informed choice. Unfortunately they draw
an erroneous conclusion, namely that it is inappropriate to measure uptake
as part of assessing informed choice. This is based upon a
misinterpretation of both our definition of info...
Olusanya et al debate the principles of informed choice within the
context of infant hearing screening [1]. In doing so they draw upon our
conceptualisation and measure of informed choice. Unfortunately they draw
an erroneous conclusion, namely that it is inappropriate to measure uptake
as part of assessing informed choice. This is based upon a
misinterpretation of both our definition of informed choice and its
measurement.
Based on the decision-making literature [2], we have proposed an
operational definition of informed choice:
“one that is based on relevant knowledge, consistent with the decision
maker’s values and behaviourally implemented” [3].
There are two types of informed choice: one, an informed choice to decline
screening, where someone with good knowledge and negative attitudes
towards themselves undergoing screening does not undergo screening; and
second, an informed choice to accept screening where someone with good
knowledge and positive attitudes towards themselves undergoing screening,
undergoes screening. An assessment of informed choice therefore requires
an assessment of knowledge, attitudes and the consistency between
attitudes and screening behaviour, to determine whether screening
behaviour, usually referred to as uptake, reflects the attitudes of the
person offered screening. This definition and model places no value on
whether the choice made is to accept or to decline screening: both such
choices can be informed and therefore represent a positive outcome of
screening.
Olusanya et al have also misinterpreted the policy of informed choice
in the context of screening [4]. The goal of an informed choice strategy
for screening is not for everyone to have positive attitudes towards
undergoing the procedure, but rather that people act consistently with
their own values, not those of others including healthcare professionals.
There are some situations where there is one clear choice and healthcare
professionals recommend a course of action for example the need for an
emergency laporatomy or the need to reduce a diuretic dose in someone with
a low serum potassium [5]. Undergoing a screening test does not fall into
this category.
We hope this serves to clarify the misunderstanding that Olusanya and
colleagues appear to be labouring under both with regard to the concept of
informed choice and its operationalisation.
References
(1). Olusanya BO, Luxon LM, Wirz SL. Infant hearing screening:route to
informed choice. Archives of Disease in Childhood 2004;89:1039-40.
(2). Bekker H, Thornton JG, Airey C, Connelly J, Hewison J, Robinson M
et al. Informed decision making: an annotated bibliography and systematic
review. Health Technology Assessment 1999;3.
(3). Marteau TM, Dormandy E, Michie S. A measure of informed choice.
Health Expectations 2001;4:99-108.
(4). National Screening Committee. Second Report of the UK National
Screening Committee. 2000. London, Department of Health.
(5). Whitney S, McGuire A, McCullough L. A typology of shared decision
making, informed consent and simple consent. Annals of Internal Medicine
2003;140:54-9.
We read with interest the recent letter of Laguda et al[1], advising
vigilance in reading food labels in those with food allergies. We would
suggest that this vigilance should include drug information sheets,
particularly in those who are allergic to Soya. Soya is used in the
pharmaceutical industry as an excipient, most notably in Ipratropium
Bromide metered dose inhalers (Atrovent) although...
We read with interest the recent letter of Laguda et al[1], advising
vigilance in reading food labels in those with food allergies. We would
suggest that this vigilance should include drug information sheets,
particularly in those who are allergic to Soya. Soya is used in the
pharmaceutical industry as an excipient, most notably in Ipratropium
Bromide metered dose inhalers (Atrovent) although not in the nebuliser
solution.
This was brought to our attention after a 2 year old girl with
multiple allergies and asthma presented with symptoms of wheeze,
difficulty in breathing and vomiting. She was prescribed Atrovent inhalers
on her discharge from hospital. Her mother happened to read the patient
information sheet that came with the Atrovent inhaler, and discovered it
to contain Soya. The girl’s persistent vomiting stopped after
discontinuing the Atrovent. Given that vomiting was a prominent presenting
symptom of the girl’s illness, we hesitate to attribute its persistence
solely to the use of Atrovent inhalers. Nevertheless, it prompted a
literature search which revealed several case reports of adverse reactions
to Atrovent, including two of anaphylaxis in adults allergic to Soya, who
were given Atrovent inhalers for the treatment of asthma.[2,3] In view of
this, we feel that Atrovent should be prescribed with caution in patients
with Soya allergy; as it may in fact cause paradoxical bronchospasm and
worsening respiratory symptoms.[4]
References
(1). Laguda B, Coren ME, Lack G. Read the label carefully (Letter).
Arch Dis Chil 2004; 89; 797
(2). Fine SR. Possible reactions to Soya lecithin in aerosols (Letter).
J Allergy Clin Immunol 1991; 87: 600.
(3). Bone WD, Admundson DE. An unusual case of severe anaphylaxis due
to ipratropium bromide inhalation (Letter). Chest 1993; 101: 981-982.
(4). Connolly C. Adverse reaction to ipratropium bromide. Br Med J
1982; 285: 934-935
We read with interest the letter discussing bloodless treatment of
infants with haemolytic disease [1], which highlighted the successful use of
erythropoietin and D-penicillamine. We wish to contribute to the
discussion of the use of erythropoietin
with a case report:
Mrs M (G2 P1), a Jehovah’s Witness, presented at 12 weeks with high
avidity anti-D antibodies (9.5 I.U.), and anti-JKa antib...
We read with interest the letter discussing bloodless treatment of
infants with haemolytic disease [1], which highlighted the successful use of
erythropoietin and D-penicillamine. We wish to contribute to the
discussion of the use of erythropoietin
with a case report:
Mrs M (G2 P1), a Jehovah’s Witness, presented at 12 weeks with high
avidity anti-D antibodies (9.5 I.U.), and anti-JKa antibody titres of 1
I.U. The role of blood products was discussed with the parents, who wished
to avoid their use. Other treatment options were discussed, including
iron, erythropoietin and minimal phlebotomy. The anti-D antibody level
peaked at 31 weeks at 14.1 I.U. Baby M was born in good condition at 37+5
weeks. The cord bilirubin (SBR) was high, and the Direct Coombs Test (DCT)
was strongly positive. Phototherapy was started and SBR and haemoglobin
(Hb) were monitored with capillary blood gas analysis, with formal
laboratory samples sent daily, to minimise iatrogenic blood loss.
Folic acid (100mcg od), Sytron (2ml bd) and erythropoietin (750 i.u.
subcut. three times a week) were commenced on day 5. At discharge (day 19)
the Hb reached a nadir of 8.6g/dl with no reticulocytes. By 6 weeks the Hb
was 11.8 g/dl, with a reticulocyte count of 18x 109 and the DCT was still
strongly positive. Erythropoietin was discontinued and the Hb and
reticulocyte count remained stable at 3 months.
The rate of SBR rise in the first 12 hours and high antibody titres would
have made exchange transfusion a reasonable option, although Baby M
remained asymptomatic. However adequate fluids and phototherapy
immediately after birth proved sufficient. Further blood loss was reduced
by minimal phlebotomy, and erythropoiesis maximised with folic acid, iron,
and erythropoietin acting in synergy [2].
Recombinant erythropoietin was ethically acceptable to baby M’s parents
and can reduce transfusions for isoimmune-haemolytic disease (such as ABO
[3] ) and subsequent anaemia. Elevated endogenous erythropoietin might be
expected in rhesus-haemolytic disease, with recombinant erythropoietin
providing little extra erythropoiesis. However erythropoietin levels
analysed in babies with rhesus-haemolytic disease are unexpectedly low,
with associated bone marrow suppression [4]. In this case, while on
erythropoietin, the Hb continued to rise despite a strongly positive DCT,
(still present postnatally at six weeks) and ceased rising off
erythropoietin. In addition the reticulocyte count improved markedly, and
continued to rise off erythropoietin.
A six-week course of erythropoietin costs about £350, which is
similar to transfusion costs. One unit of leucodepleted, irradiated, CMV
negative blood is £113 [5], in addition to the cost of exchange equipment.
Rising transfusion costs and limited blood product reserves make
erythropoietin more cost-effective in rhesus-haemolytic disease. In
addition erythropoietin has few side-effects, while 3% of neonates have
transfusion reactions [2].
Minimal phlebotomy is important in neonatal management to avoid blood
products. Hb and SBR are available by blood gas analysis, and requires
95mcl of blood, compared to 500mcl for serum electrolytes and SBR, and
500mcl for a full blood count. Baby M lost an estimated 24 ml of blood
for tests during his inpatient stay (10.6% of blood volume).
Throughout the antenatal and postnatal period, consistent and regular
communication with the parents maintained a good rapport, and it was
emphasised that all treatment modalities would be explored before
obtaining a specific treatment order for blood products.
We believe that these strategies helped Baby M overcome complicated
maternal antibody isoimmunization without the use of blood products, and
that recombinant erythropoietin is cost-effective, safe and could make up
for a shortfall in endogenous erythropoietin production.
References
(1). Lakatos L Bloodless treatment of infants with haemolytic disease.
Arch Dis Child 2004; 89-1076.
(2). Bader D. Kugelman A.Weinger-Abend M et al The role of high-dose oral
iron supplementation during erythropoietin therapy for anemia of
prematurity. J Perinatology. 21(4):215-20, 2001 Jun.
(3). Lakatos L. Csathy L. Nemes E. “Bloodless” treatment of a Jehovah’s
Witness infant with ABO hemolytic disease. J Perinatology 19(7); 530-2;
1999 Oct-Nov
(4). Thorp JA, O’Connor T, Callenbach J et al. Hyporegenerative anemia
associated with intrauterine transfusion in Rhesus Haemolytic disease. Am
J Obs Gynae 1991; 165(1); 79-81.
(5). Figures from Southampton University Pathology Services.
Professor David’s review provides a welcome summary of the Code of
Guidance for Expert Witnesses in Family Proceedings. All Paediatricians
who undertake this type of work should be familiar with the Code of
Guidance and have due regard to it. However, Professor David also goes on
to express some highly personal opinions which, whilst forcefully argued,
are unreferenced and not evidence based. The most...
Professor David’s review provides a welcome summary of the Code of
Guidance for Expert Witnesses in Family Proceedings. All Paediatricians
who undertake this type of work should be familiar with the Code of
Guidance and have due regard to it. However, Professor David also goes on
to express some highly personal opinions which, whilst forcefully argued,
are unreferenced and not evidence based. The most obvious example in the
article is Professor David’s views on interviewing the parents or carers.
He comments that "a paediatrician who does not attempt to interview the
parents risks being criticised for by-passing the usual routines and
failing to consider all aspects of the case", He goes on to say that
paediatricians willing to make a confident diagnosis of abuse without ever
meeting the parents risk making parents exceptionally aggrieved, alluding
to recent press publicity.
The undersigned are all experienced in the field of child protection
and between us have considerable experience of expert witness work. In our
experience, a substantial proportion of Expert Witness Reports are
prepared on the basis of a paper review. This has hitherto been regarded
as perfectly sound medical practice, which is not explicitly discouraged
in any of the published Expert Witness guidance. We would suggest that
Professor David’s views should not be accepted unquestioningly, and that
this issue should be debated openly.
It is undeniable that treating paediatricians need to take a good
history from parents, carers or others, especially where child abuse is
being considered in the differential diagnosis. The situation is
different, however, for an Expert Witness who assesses the case many
months after the parents have been confronted with the initial concerns
about child abuse. The parents are likely to have had many opportunities
to discuss their case and rehearse their history, for example in case
conferences, meetings of professionals and with their lawyers. Usually
they will have produced detailed witness statements in connection with
civil and/or criminal proceedings. Interviewing carers in this context is
not something which paediatric training fully prepares you for, and even
experienced paediatricians may have little experience of this. There are
significant risks:
1. Parents, whether innocent or not, will naturally attempt to
idealise their histories and portray themselves or other carers in a
favourable light. Guilty carers are likely to be untruthful. It is
therefore impossible for the Paediatrician to know how much weight to
attach to the history given by the carer at this point in time.
This poses
dual risks: Paediatricians may become prejudiced against an innocent carer
if they perceive them as unreliable, or conversely, they may be ‘taken in’
by a guilty carer who has distorted the history. This can result in the
paediatrician being drawn inappropriately into advocating for the carer
and failing to be objective about the other medical evidence. It may
even result in the paediatrician meeting with the carers, deciding whether
they feel that they are telling the truth or not and then inappropriately
interpreting the medical evidence in a way that supports that view. We
must not forget that the paediatrician’s prime role is to consider whether
the child has suffered harm, not to attribute guilt.
2. Given the long delay between the suspected abuse event and the
involvement of the Expert Witness, there is a risk that perfectly innocent
errors may creep into the history provided by the carers. There is a risk
that the doctor or the court would be prejudiced against the parents in
this situation.
3. There is a further risk for the unwary in potentially becoming
prejudiced against parents who have mental health problems, learning
difficulties, unusual personalities or strange affect. This is also to
be guarded against, as it is essential for paediatricians to remain
objective.
4. The Expert Witness Guidance specifically forbids paediatricians to
seek to resolve disputed issues of fact in their reports. There is a
risk that in interviewing the family and generating new information the
paediatrician may be drawn into this particular trap.
5. In some cases there may be a risk of physical harm or intimidation
of the Expert Witness. Often we are invited to meet with the family in
their own home and without chaperones. This also leaves doctors
vulnerable to false accusations concerning their behaviour in interviews.
The carers may try to challenge or ‘cross-examine’ the doctor at
interview. Doctors need to consider carefully their own health and safety
in these circumstances.
6. The parents may misinterpret, misrepresent or take ‘false hope’
from things that the paediatrician has said to them, or may press for a
provisional opinion on the case, which of course should not be given.
7. Not infrequently, parents or their advocates are suspicious about
the paediatrician’s motive in wanting to interview the family, even when
the doctor is jointly instructed and acting in a completely neutral
capacity. They may insist on the interview being recorded and transcribed,
which adds delay and expense. If the interview is not recorded the carer
may later deny something that they said to the paediatrician if it is
unhelpful to their case.
8. Given that the Courts are experiencing extreme difficulty in
recruiting Expert Witnesses, adding a further obligatory interview,
regardless of its relevance, may even further deter paediatricians from
taking on cases.
9. The new Protocol for Family Law cases was introduced to avoid
delay in proceedings and a requirement to interview carers in all cases
would inevitably add delay.
10. Parents often find interviews such as this very stressful. This is only justified if there is clear benefit.
11. Finally, Professor David’s views imply that avoidance of parental
upset is a priority. It is to be expected that parents will be upset about
the diagnosis of abuse, particularly if they are implicated. However,
there is no evidence of which we are aware to suggest that the parents
will be less upset, or less likely to complain, if the paediatrician meets
with them.
Earlier this year, the President of the Royal College of
Paediatrics and Child Health drew attention to an ‘orchestrated campaign’
against Paediatricians involved in child protection. Certain well-known
campaigners, accused parents and journalists often refer to the fact that
a Paediatric Expert Witness had not met the family before coming to a
diagnosis, in an attempt to discredit them. In this context, the idea that
interviews with parents or carers should be conducted purely to appease
them and reduce the likelihood of them complaining is highly controversial
and there is no reason to believe that goal would be achieved. Where
complaints are received, for example by an NHS Trust or the GMC, it is
important that the doctor’s performance is judged on the basis of
currently accepted and ‘reasonable’ medical practice, and that the
opinions of those making these judgements are not influenced by skilfully
argued but personal and controversial views such as those expressed by
Professor David.
In some cases, of course the Expert Witness will wish to meet with
the carers before coming to a diagnosis. We would not argue that it is
wrong to do so subject to the cautions mentioned above, but it should not
be obligatory as suggested by Professor David. Ultimately the more
objective evidence is contained in the medical records. A careful review
of this basic information is often needed before deciding whether to take
a further history from the parents. Whether or not the parents or carers
have been interviewed should not be regarded as a measure of the quality
of the report, and there are many occasions when reports based on paper
reviews have been highly commended by Courts. In each case Paediatricians
need to carefully weigh up the pros and cons of interviewing the carers
and justify their actions.
Professor David quite correctly entreats all paediatricians to
consider both sides of the argument, acknowledge where opinions are
controversial or open to challenge, and present material that does not
support the Expert’s opinion as well as that which does. He also points
out that non-medical professionals such as lawyers and judges may over-
interpret medical theories. These cautions are well made, but we would
suggest that they should also apply to controversial opinions expressed in
the medical literature, particularly where they relate to Expert Witness
work and could have serious unwanted consequences if they were to pass
without comment into medical or judicial dogma.
Declaration of Interests: All the co-signatories undertake child
protection work and most have acted as expert witnesses in child
protection cases. All have had the opportunity to comment on drafts of
this letter and are in broad agreement with its content. Several of the co
-signatories expressed a slightly divergent opinion, feeling that a
paediatric expert witness in a child protection case should never
interview the carer as this would be a challenge to their objectivity.
Drs. Bannon and Mather give a gloomy prognosis for
the future of community paediatrics which is not new:
many of the same views were expressed in the
RCPCH review of the field by Craft et al. However
there are a number of reasons for being more positive
and presenting a clear vision.
First, we should stop saying that community
paediatrics is difficult to explain. I say that 'I practic...
Drs. Bannon and Mather give a gloomy prognosis for
the future of community paediatrics which is not new:
many of the same views were expressed in the
RCPCH review of the field by Craft et al. However
there are a number of reasons for being more positive
and presenting a clear vision.
First, we should stop saying that community
paediatrics is difficult to explain. I say that 'I practice
holistic general paediatrics'. This means simply caring
for the
whole child; this should be the general paediatrics of
the future, applicable in or out of hospital. I do not
consider community paediatrics to be a specialty: it is
holistic general paediatrics. Hence all
trainees need to imbibe its philosophy, including the
incorporation of a mental health and a population
perspective. There are specialties of community
paediatrics which would be seen in the same way as
organ-based specialties.
Second, we have to get the training right - this
means the training of all paediatricians. We can do
this by
developing a holistic approach in SpR training
including mental health, disability, social paediatrics,
advocacy and a population perspective. This can be
done and there are many good examples in the UK, as
well as in other countries. For example, the following
are constituents of training programmes supported by
the American Academy of Pediatrics:
a continuity clinic where the trainee gives service over a
two year period - to understand the continuity of health
care.
A well organised training module on community -based
services.
An advocacy project, in which the trainee engages with
a real problem of health care and seeks to resolve it.
These and other proposals are being developed by
members of the Equity Project between the RCPCH
and the AAP.
We can make the model for the paediatrician of the
future a holistic paediatrician: if we look forward rather
than back.
Dear Editor,
McGovern and Smith [1] have embarked upon the welcome development of an evidence based algorithm for the investigation of infants presenting with an apparent life threatening event (ALTE). Unfortunately, they do not distinguish between coincidence and causality. Recurrent vomiting occurs in over 60% of 4 month old babies [2], and it is therefore unsurprising that gastro-oesophageal reflux is commonly...
Dear Editor,
In reading this piece and the published response concerning the merits of personal interviews in child protection cases, I was struck by the sentence introducing the topic which reads: "Most paediatricians would not dream of giving a clinical opinion without taking a history".
Accordingly this week I kept a diary of clinical opinions given. It was a quiet week "off service", there were only...
Dear Editor,
Professor David's article [1] was, in the majority a helpful guide to those involved in this specialised work. I wonder how many of the readers are involved in this sort of work?
As a recently qualified general paediatrician I was surprised to read his recommendation that expert witnesses should interview the family. In the few child protection cases that I have been involved in as a witnes...
Dear Editor,
I enjoyed Ricci et al's article on the ' Pitfalls of adverse event reporting..'.This is a difficult issue for medical departments.As well as a robust reporting system it is important to have a forum to deal with the incidents and educate staff.
Our paediatric unit has had a Clinical Practice Meeting for the past 2 years. This happens every 6-8 weeks, it is multidisciplinary (nursing,doc...
Dear Editor,
There is a bias in research on treatments that sometimes manifests itself in odd ways. The preference for a one-tailed test, for instance, may lead us to focus on whether a treatment makes things better, but leads us to miss important details when a treatment makes things worse. This is an important point when testing treatments against such alternatives.
Before turning to the central point,...
Dear Editor,
Olusanya et al debate the principles of informed choice within the context of infant hearing screening [1]. In doing so they draw upon our conceptualisation and measure of informed choice. Unfortunately they draw an erroneous conclusion, namely that it is inappropriate to measure uptake as part of assessing informed choice. This is based upon a misinterpretation of both our definition of info...
Dear Editor,
We read with interest the recent letter of Laguda et al[1], advising vigilance in reading food labels in those with food allergies. We would suggest that this vigilance should include drug information sheets, particularly in those who are allergic to Soya. Soya is used in the pharmaceutical industry as an excipient, most notably in Ipratropium Bromide metered dose inhalers (Atrovent) although...
Dear Editor,
We read with interest the letter discussing bloodless treatment of infants with haemolytic disease [1], which highlighted the successful use of erythropoietin and D-penicillamine. We wish to contribute to the discussion of the use of erythropoietin with a case report:
Mrs M (G2 P1), a Jehovah’s Witness, presented at 12 weeks with high avidity anti-D antibodies (9.5 I.U.), and anti-JKa antib...
Dear Editor,
Professor David’s review provides a welcome summary of the Code of Guidance for Expert Witnesses in Family Proceedings. All Paediatricians who undertake this type of work should be familiar with the Code of Guidance and have due regard to it. However, Professor David also goes on to express some highly personal opinions which, whilst forcefully argued, are unreferenced and not evidence based. The most...
Dear Editor,
Drs. Bannon and Mather give a gloomy prognosis for the future of community paediatrics which is not new: many of the same views were expressed in the RCPCH review of the field by Craft et al. However there are a number of reasons for being more positive and presenting a clear vision.
First, we should stop saying that community paediatrics is difficult to explain. I say that 'I practic...
Pages